We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PE
851
DELISTED
PARSLEY ENERGY INC
PE
| $769K | ﹤0.01% |
26,076
+8,870
| +52% | +$263K |
|
852
Xencor
XNCR
$1.6B
| $765K | ﹤0.01% |
18,200
-500
| -3% | -$20.4K |
|
|
MYOK
853
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $753K | ﹤0.01% |
12,600
-350
| -3% | -$20.6K |
|
|
SNV
854
DELISTED
Synovus
SNV
| $749K | ﹤0.01% |
15,100
| – | – |
|
855
Polaris
PII
$3.97B
| $740K | ﹤0.01% |
6,557
-226
| -3% | -$25.2K |
|
856
East-West Bancorp
EWBC
$18.1B
| $739K | ﹤0.01% |
11,027
-502
| -4% | -$32.2K |
|
|
JHG
857
DELISTED
Janus Henderson
JHG
| $738K | ﹤0.01% |
+27,162
| New | +$792K |
|
858
Imperial Oil
IMO
$62.3B
| $736K | ﹤0.01% |
23,272
| – | – |
|
|
ACOR
859
DELISTED
Acorda Therapeutics
ACOR
| $735K | ﹤0.01% |
214
+9
| +4% | +$27.9K |
|
860
Helmerich & Payne
HP
$4.18B
| $731K | ﹤0.01% |
10,569
-8,200
| -44% | -$523K |
|
861
Insmed
INSM
$29.4B
| $731K | ﹤0.01% |
33,500
-900
| -3% | -$20.3K |
|
|
TPIC
862
DELISTED
TPI Composites
TPIC
| $711K | ﹤0.01% |
25,000
| – | – |
|
863
Pinnacle West Capital
PNW
$12B
| $707K | ﹤0.01% |
8,442
+1,312
| +18% | +$105K |
|
864
Telkom Indonesia
TLK
$14.7B
| $705K | ﹤0.01% |
30,118
| – | – |
|
865
Bausch Health
BHC
$2.37B
| $703K | ﹤0.01% |
29,800
-33,000
| -53% | -$756K |
|
866
Fluor
FLR
$7.3B
| $692K | ﹤0.01% |
11,384
-5,568
| -33% | -$303K |
|
|
GTHX
867
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $691K | ﹤0.01% |
11,500
-300
| -3% | -$16.4K |
|
868
Autoliv
ALV
$8.92B
| $690K | ﹤0.01% |
7,306
-13,386
| -65% | -$1.28M |
|
|
ZAYO
869
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $686K | ﹤0.01% |
18,753
-23,613
| -56% | -$862K |
|
870
Equinor
EQNR
$97.4B
| $683K | ﹤0.01% |
26,000
| – | – |
|
871
Federated Hermes
FHI
$4.71B
| $678K | ﹤0.01% |
29,700
-4,000
| -12% | -$94.1K |
|
|
ETP
872
DELISTED
Energy Transfer Partners, L.P.
ETP
| $674K | ﹤0.01% |
30,000
| – | – |
|
873
CubeSmart
CUBE
$9.23B
| $672K | ﹤0.01% |
22,089
| – | – |
|
|
ZGNX
874
DELISTED
Zogenix, Inc.
ZGNX
| $666K | ﹤0.01% |
14,300
-400
| -3% | -$20.4K |
|
875
Aptiv
APTV
$10.3B
| $664K | ﹤0.01% |
+7,900
| New | +$722K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.